Systemic Chemotherapy for Resectable Hepatic Colorectal Metastases: Adjuvant, Neoadjuvant, or Not at All?

被引：0

作者：

Morgan, Clinton T. ^{[1
]}

Cho, Clifford S. ^{[2
]}

机构：

[1] Univ Wisconsin Sch Med & Publ Hlth, Dept Surg, Madison, WI 53726 USA

[2] Univ Wisconsin Sch Med & Publ Hlth, Dept Surg, Sect Surg Oncol, J4-703 Clinical Sci Ctr,600 Highland Ave, Madison, WI 53792 USA

来源：

CURRENT SURGERY REPORTS | 2014年 / 2卷 / 05期

关键词：

Colorectal adenocarcinoma; Liver metastases; Surgery; Systemic chemotherapy; Neoadjuvant; Adjuvant;

D O I：

10.1007/s40137-014-0052-3

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

The contemporary management of hepatic colorectal adenocarcinoma metastasis relies on the multi-disciplinary use of both local operative resection and systemic chemotherapy. This article will discuss the principles and data that are of relevance in determining the optimal way to combine these treatment modalities. In so doing, we will explore the issue of when and whether to administer chemotherapy for patients with resectable hepatic metastases.

引用

页数：8

共 50 条

[41] Adjuvant regional chemotherapy following resection of colorectal hepatic metastases
Riesener, KP
Winkeltau, G
Kasperk, R
Cheng, L
Schumpelick, V
[J]. CHIRURG, 1998, 69 (07): : 741 - 746
[42] Neoadjuvant and Adjuvant Therapy Combined With Resection of Hepatic Colorectal Cancer Metastases
Alberts, Steven R.
[J]. CURRENT COLORECTAL CANCER REPORTS, 2006, 2 (02) : 81 - 84
[43] Letter to the editor: the benefit of adjuvant chemotherapy for resectable colorectal cancer liver metastases
Chen Zhong
Kainan Li
Jingwang Bi
Baocheng Wang
[J]. International Journal of Colorectal Disease, 2013, 28 : 1455 - 1456
[44] Multicentre study of perioperative versus adjuvant chemotherapy for resectable colorectal liver metastases
Allard, M-A
Nishioka, Y.
Beghdadi, N.
Imai, K.
Gelli, M.
Yamashita, S.
Kitano, Y.
Kokudo, T.
Yamashita, Y-, I
Cunha, A. Sa
Vibert, E.
Elias, D.
Cherqui, D.
Goere, D.
Adam, R.
Baba, H.
Hasegawa, K.
[J]. BJS OPEN, 2019, 3 (05): : 678 - 686
[45] Letter to the editor: the benefit of adjuvant chemotherapy for resectable colorectal cancer liver metastases
Zhong, Chen
Li, Kainan
Bi, Jingwang
Wang, Baocheng
[J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2013, 28 (10) : 1455 - 1456
[46] SYSTEMIC ADJUVANT CHEMOTHERAPY AFTER RESECTION OF COLORECTAL CANCER METASTASES
Brandi, G.
Derenzini, E.
Pantaleo, M. A.
Di Battista, M.
Ravaioli, M.
Ercolani, G.
Grazi, G. L.
Fanello, S.
Di Marco, M.
Nobili, E.
Hakim, R.
Poggi, R.
Palmerini, E.
Biasco, G.
[J]. ANNALS OF ONCOLOGY, 2004, 15 : 66 - 66
[47] Perioperative chemotherapy for resectable hepatic metastases
Kopetz, Scott
Vauthey, Jean-Nicolas
[J]. LANCET, 2008, 371 (9617): : 963 - 965
[48] Systematic Review of Randomized and Nonrandomized Trials of the Clinical Response and Outcomes of Neoadjuvant Systemic Chemotherapy for Resectable Colorectal Liver Metastases
Terence C. Chua
Akshat Saxena
Winston Liauw
Adel Kokandi
David L. Morris
[J]. Annals of Surgical Oncology, 2010, 17 : 492 - 501
[49] Neoadjuvant chemotherapy for non-/resectable metastases
Folprecht, Gunnar
[J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S52 - S60
[50] Systematic Review of Randomized and Nonrandomized Trials of the Clinical Response and Outcomes of Neoadjuvant Systemic Chemotherapy for Resectable Colorectal Liver Metastases
Chua, Terence C.
Saxena, Akshat
Liauw, Winston
Kokandi, Adel
Morris, David L.
[J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (02) : 492 - 501

← 1 2 3 4 5 →